[
  {
    "uuid": "647378d746caa03ce027f70b18c5182ae4f1b02c",
    "url": "https://gestion.pe/publirreportaje/construye-bien-cerca-de-una-decada-impulsando-la-seguridad-en-las-viviendas-peruanas-noticia",
    "ord_in_thread": 0,
    "author": "Redacción Gestión",
    "published": "2025-04-16T21:06:00Z",
    "title": "Construye Bien: cerca de una década impulsando la seguridad en las viviendas peruanas",
    "text": "Construye Bien, una plataforma impulsada por Sodimac y Maestro, nació con el propósito de concientizar, educar y asesorar a los peruanos sobre la importancia de una construcción segura. Desde sus inicios, hace casi una década, el programa ha ido evolucionando y creciendo de manera constante, llegando cada vez a más hogares. Hoy en día, impacta a miles de personas brindando la información necesaria, promoviendo prácticas de construcción responsable y el uso de materiales adecuados para reducir la vulnerabilidad de las viviendas.\n“Construye Bien ha sido una plataforma clave en la educación sobre construcción segura en el Perú. Nuestro objetivo es seguir promoviendo, en alianza con las marcas líderes del mercado, el acceso a información confiable y asesoría técnica para que cada vez más peruanos construyan con seguridad y reduzcan los riesgos ante un desastre. Este compromiso es permanente y seguiremos trabajando para impulsar la formalización y el acceso a mejores prácticas”, destacó Piero Campos, Gerente Comercial de Sodimac Perú.\nAcompáñanos a conocer su historia y sus principales iniciativas:\n2017 - Nacimiento de Construye Bien\nAnte la alta tasa de viviendas autoconstruidas en el país, que el 2017, según Cámara Peruana de la Construcción (Capeco), solo en Lima llegaba al 70%, nació Construye Bien, una iniciativa pensada para capacitar a maestros de obra, autoconstructores y propietarios, asegurando que las edificaciones cumplan con los estándares de seguridad estructural.\n2018 - El impacto de la “Prueba Maestra”\nLa plataforma marcó un hito en la concientización sobre los riesgos de la construcción informal con la “Prueba Maestra”. Este desafío consistió en someter una vivienda edificada con buenas prácticas y otra informal a movimientos similares a los generados por un sismo de gran magnitud. Mientras la primera se mantuvo en pie, la informal colapsó completamente. El experimento se realizó con el apoyo de instituciones especializadas como el Instituto Geofísico del Perú (IGP), la Cámara Peruana de la Construcción (CAPECO) y el Centro de Estudios y Prevención de Desastres (PREDES).\n2019-2022 - Expansión digital: conectando con más peruanos\nCon el objetivo de llegar a más peruanos, Construye Bien reforzó su presencia en plataformas digitales y redes sociales. Mediante videos y materiales gráficos, lograron educar al público de manera más ágil y dinámica.\nSodimac y Maestro reafirmaron su compromiso con la seguridad enfocándose en tres aspectos clave:\n2023 - Construye Bien inicia una nueva etapa\nSodimac y Maestro reafirmaron su compromiso con la construcción segura al relanzar la plataforma Construye Bien y presentar a la Brigada Construye Bien, un equipo de cuatro expertos que enseñaban a resolver los problemas que amenazan la integridad de las viviendas y las familias peruanas.\nLa brigada se enfocó en cuatro áreas clave:\n“Todos somos Brigada Construye bien”\nEn septiembre de 2023, Sodimac y Maestro lanzaron la iniciativa “Todos Somos Brigada Construye Bien”, con la finalidad de capacitar a la población sobre la preparación, respuesta y rehabilitación de los potenciales daños que pudiera causar en las viviendas el Fenómeno El Niño.\nGracias a esta iniciativa, se brindaron talleres de capacitación y videos tutoriales sobre la protección de los hogares ante inundaciones, filtraciones y deslizamientos.\n2024-2025 - El regreso de la “Prueba Maestra”\nFrente al riesgo sísmico que enfrenta Perú, y considerando que cerca del 76% de las viviendas podrían no soportar un terremoto, la “Prueba Maestra” de Construye Bien regresó para reforzar el mensaje sobre la importancia de una construcción segura.\nEsta prueba volvió en un nuevo formato, adaptado a las plataformas digitales, y con una estrategia más interactiva.\nConstruye bien: compromiso consolidado\nA lo largo de estos años, Sodimac y Maestro han asumido un rol activo en la concientización sobre la construcción segura, siempre alineados a la formalización del sector. Con ello, ha impulsado a Construye Bien a adaptarse a las cambiantes necesidades del mercado y de la población. Actualmente, la plataforma aplica nuevas estrategias para lograr un impacto real en la seguridad estructural del país.\nLucha contra la informalidad\nEste 2025, Construye Bien también viene combatiendo la informalidad y el uso de los productos ‘bamba’, trabajando para demostrar la importancia de adquirir materiales de calidad y así proteger la vivienda y la integridad familiar.\n¿Quieres saber más sobre esta iniciativa? Visita las redes sociales de Sodimac Constructor.\nTikTok e Instagram y también puedes encontrarlos en Facebook y YouTube.\nSé parte de un Perú más seguro.\nReportaje Publicitario",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
      "Social Issue",
      "Human Interest",
      "Politics"
    ],
    "topics": [
      "Social Issue->public housing",
      "Social Issue->communities",
      "Social Issue->social services",
      "Politics->civil rights",
      "Politics->government",
      "Politics->government policy"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [
      "https://www.facebook.com/SodimacConstructorPeru/",
      "https://www.tiktok.com/@sodimacconstruyeperu/",
      "https://www.youtube.com/c/SodimacConstructorPer%C3%BA/",
      "https://www.instagram.com/sodimacconstruyeperu/",
      "https://www.facebook.com/SodimacConstructorPeru",
      "https://facebook.com/SodimacConstructorPeru/",
      "https://tiktok.com/@sodimacconstruyeperu/",
      "https://instagram.com/sodimacconstruyeperu/",
      "https://www.tiktok.com/@sodimacconstruyeperu",
      "https://www.instagram.com/sodimacconstruyeperu",
      "https://www.youtube.com/c/SodimacConstructorPer%C3%BA",
      "https://youtube.com/c/SodimacConstructorPer%C3%BA/"
    ],
    "entities": {
      "persons": [
        {
          "name": "Piero Campos",
          "sentiment": "none"
        }
      ],
      "locations": [],
      "organizations": [
        {
          "name": "Gerente Comercial de Sodimac Perú",
          "sentiment": "neutral",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-17T00:46:49.044+03:00",
    "updated": "2025-04-17T00:46:49.044+03:00"
  },
  {
    "uuid": "1d431551bfd47784db2a8611e75c4b265ba9f226",
    "url": "https://www.montanasports.com/category/high-school/football/no-3-frenchtown-football-playing-for-more-than-just-points-on-the-scoreboard",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Derek Joseph",
    "published": "2024-09-19T17:01:00Z",
    "title": "No. 3 Frenchtown football playing for more than just points on the scoreboard",
    "text": "FRENCHTOWN — Ahead of Frenchtown's homecoming game this weekend against No. 1 Dillon, the team is 3-0 and every touchdown it scores this year has a lot more at stake than just points on the scoreboard. As hard as the No. 3-ranked Broncs have been working on the field this season, the team has been working just as hard off the field to promote the team’s new initiative — Our Team, Our Cause. The initiative was spearheaded by Broncs assistant coach Brian Labbe who wanted the team to decide together on a worthy charity for fans and parents to donate. “So this last spring we had the boys vote on organizations and they picked Camp Mak-a-Dream over in Gold Creek, Montana,” Labbe said, “which is a summer camp for kids and families who have been affected by cancer.” Anyone who donates is pledging money to every touchdown Frenchtown scores in the season. George Laufenberg, Camp Mak-a-Dream’s executive director, expressed the importance of Frenchtown’s football team creating this cause. “It means the world to us to have the support of coach Brian and the Broncs in Frenchtown because they absolutely have other causes they could be leaning into,” Laufenberg said. “But we at camp Mak-a-Dream have the privilege of serving kids and teens and families battling cancer from Montana and across the country and we are so thrilled to have the support of the folks from Frenchtown as we get to carry out that mission.” While the team’s main focus is winning the homecoming game against Dillon, the coaching staff has noticed adding extra incentive to their touchdowns has made the team work harder. Labbe expressed how the team has taken the initiative to heart. “A big thing I think that fires them up a little bit, we always bring it up every week to remind them of that extra thing. These boys don’t need a whole lot of extra motivation on the field but this one I think actually gave them one,” he said. Frenchtown kicks off its homecoming Class A showdown against top-ranked Dillon on Friday night at 7 p.m.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Sport",
      "Human Interest",
      "Lifestyle and Leisure"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null
    },
    "rating": null,
    "crawled": "2024-09-20T00:23:31.803+03:00",
    "updated": "2024-09-27T05:07:54.856+03:00"
  },
  {
    "uuid": "606f760f8cf163a4a747f43d4f247c92fb5cf1f6",
    "url": "https://techstory.in/microsoft-lays-off-650-employees-from-gaming-division-following-activision-blizzard-acquisition",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Anochie Esther",
    "published": "2024-09-12T23:58:00Z",
    "title": "Microsoft Lays Off 650 Employees from Gaming Division - TechStory",
    "text": "Microsoft has announced another wave of layoffs in its gaming division, cutting approximately 650 jobs. This decision comes just eight months after the company let go of 1,900 employees following its $68.7 billion acquisition of Activision Blizzard. While the latest round of cuts is smaller, it reflects Microsoft’s ongoing efforts to restructure its gaming division for long-term success after the acquisition.\nSince acquiring Activision Blizzard, Microsoft has been making significant adjustments to its gaming division. The acquisition brought several prominent game franchises, including Call of Duty, World of Warcraft, and Candy Crush, under Microsoft’s umbrella, elevating its presence in the gaming industry. However, the massive acquisition required restructuring to align resources and teams efficiently.\nIn an internal memo shared with employees and later leaked by IGN, Phil Spencer, head of Xbox, explained that these layoffs are part of efforts to streamline operations after the Activision Blizzard acquisition. He stated that the decision is part of the company’s strategy to “align our post-acquisition team structure and manage our business” to ensure long-term success, even though it results in job losses.\nFocus on Corporate and Support Roles According to Spencer’s memo, the majority of the 650 layoffs will target corporate and support roles, rather than the creative or game development teams. This strategy allows Microsoft to reduce operational costs without affecting its ability to produce games. By trimming back-end operations, the company hopes to maintain the momentum of game development and continue delivering products without disrupting production schedules.\nSpencer assured both employees and the gaming community that no games, devices, or other gaming experiences would be canceled due to the layoffs. Additionally, no studios will be closed this time, a significant difference from the earlier layoffs, which resulted in the closure of several well-known game studios, including Tango Gameworks and Arkane Austin.\n Previous Layoffs and Studio Closures The latest job cuts follow an earlier round of layoffs in January 2023, when Microsoft reduced its gaming workforce by *l1,900 employees as part of a larger company-wide layoff affecting 10,000 workers. That previous restructuring also saw the closure of multiple game studios, such as Tango Gameworks, known for Ghostwire: Tokyo, and Arkane Austin, developers of Redfall. These closures raised concerns among both gamers and industry professionals about the potential impact on Microsoft’s future game development projects.\nDespite these setbacks, Microsoft continues to emphasize its long-term strategy of investing in gaming growth. Spencer reiterated in his memo that these layoffs are necessary steps for the company to position itself for future success, particularly in light of the complexities of integrating Activision Blizzard into its existing operations.\nA key point of reassurance from Spencer’s memo is that no current game projects, hardware launches, or ongoing gaming services will be impacted by the restructuring. This is welcome news for the gaming community, which had expressed concerns about how the layoffs might affect upcoming titles or ongoing development efforts.\nSpencer emphasized that the focus of the layoffs is on improving efficiency within the company, not reducing its capacity to develop games. With a portfolio that includes popular franchises like Halo, Forza, and Gears of War, as well as new properties from Activision Blizzard, Microsoft is eager to avoid any disruptions to its game production. The company remains committed to expanding its subscription service, Xbox Game Pass, and investing in cloud gaming technologies, which are seen as pivotal to the future of gaming.\n Microsoft’s Long-Term Strategy The layoffs at Microsoft come amid a broader trend of restructuring across the tech industry, as companies adjust to evolving market conditions, rising operational costs, and changes in consumer behavior. Microsoft’s decision to focus its layoffs on corporate and support roles suggests the company is prioritizing its core strength in game development while working to optimize its operations in non-creative areas.\nThe acquisition of **Activision Blizzard** is central to Microsoft’s long-term gaming strategy, and Spencer’s memo indicates that the company is committed to ensuring a smooth integration. By eliminating redundancies and reorganizing its business, Microsoft aims to remain competitive in the increasingly crowded and rapidly changing gaming market.\nAlthough layoffs are never easy, particularly for those directly impacted, Microsoft’s decision to reduce its gaming workforce by **650 employees** appears to be a strategic move aimed at ensuring long-term success. By concentrating these cuts on corporate and support functions, the company is positioning itself to continue developing top-tier games and services without compromising its future potential.\nAs Microsoft integrates Activision Blizzard and refines its business model to reflect the expanded scale of its gaming division, its focus remains on growth and staying competitive in the global gaming market. Despite the challenges of restructuring, the company seems to be laying the foundation for continued success in the years ahead, while maintaining its commitment to innovation and quality in game development.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Economy, Business and Finance",
      "Labor",
      "Corporate News and Profiles"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "phil spencer",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "microsoft",
          "sentiment": "neutral"
        },
        {
          "name": "ign",
          "sentiment": "none"
        },
        {
          "name": "activision blizzard",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null
    },
    "rating": null,
    "crawled": "2024-09-13T09:37:09.522+03:00",
    "updated": "2024-09-13T11:14:13.955+03:00"
  },
  {
    "uuid": "19ca49c5fdf95ec391c72ea24f710a572984ed0b",
    "url": "https://www.coloradoan.com/story/life/humankind/2023/12/28/spiral-hot-dogs-photo-norman-ok-business-boom/72051213007/",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Anthony Robledo",
    "published": "2023-12-29T00:01:00Z",
    "title": "Viral photo of forlorn Spiral Hot Dogs owner leads to booming business",
    "text": "Customer's photo of forlorn owner in empty restaurant leads business to boom at OK diner Nick Chappell had never been to Spirals Hot Dogs & More before he took a photo of Scott Hosek in his empty restaurant. But after business boomed, Chappell's part of the Spirals family, Hosek says. [Anthony Robledo](https://www.usatoday.com/staff/7612431001/anthony-robledo/) An Oklahoma hot dog joint owner visibly wanted customers one day and he soon got more than he bargained for. During a slow shift on Dec. 20, a customer took a photo of Scott Hosek standing by his restaurant entrance waiting for diners and shared it on social media. Hosek would soon have no time to stand around as \" [Spirals: Hot Dogs & More](https://spiralshotdogs.com/),\" in Norman, Oklahoma, saw booming business once the post went viral. \"We immediately started doing double digits in sales,\" Hosek told USA TODAY on Thursday. \"It happened really fast to me.\" The day the photo was taken, Hosek found himself staring out the window upset his family business of four years wasn't booming as well as others ahead of Christmas. Hosek said he had no idea why Spirals saw a sudden wave of new customers after Dec. 20 until the person responsible for posting the photo, Nick Chappell, later apologized and offered to take the post down. Hosek wouldn't hear of it. \"You just wouldn't expect it. Social media is amazing. It's amazing that people get involved with it,\" he said. \"But more importantly, it's the stuff that you just don't think would work. That's what works.\" 'I will always love you': [See Dolly Parton grant Utah man's dying wish to meet her](/story/life/humankind/2023/12/26/dolly-parton-meets-longtime-fan/72033945007/) Customer knew he had to capture 'wholesome moment' Chappell visited the Norman area for his job as an Oklahoma Army National Guard. As part of their weekly hot dog Wednesday routine, Chappell and a his co-worker found Spirals on Google Maps and took a chance. Noticing Hosek gazing, Chappell decided to capture the \"wholesome moment\" on Snapchat captioning \"He has been standing here waiting on customers to come in.\" \"A good buddy of mine named Chad said, 'Hey, man, you can either post this on Facebook or I'm going to post this on Facebook. Some way or another we're going to get this guy some customers,'\" Chappell said. In a Facebook post, Chappell gave an excellent recommendation of the restaurant, complimenting their food and \"off the charts\" service. He shared a photo of his dish, the menu and of Hosek waiting for diners. Chappell was blown away by the success of the post, which has since had over 2,000 shares, and even more surprised to see over 70 guests at the diner during his next visit. \"I'm not a huge social media guy I typically don't share,\" Chappell said. \"I don't even know really the words to describe it as but it made me even that much happier that I did make a post.\" Owner adds new 'Thunderbird' item in customer's honor Hosek is showing his gratitude by adding a new item in Chappell's honor. Having named hot dogs and bowls after family members, he was more than happy to do so. The \"Thunderbird\" is a hot link with bacon, cream cheese and jalapeños, Hosek said. The meal gets its name from the Thunderbird Unit Patch for the 45th Infantry, which Chappell is a part of. The two reconnected at the restaurant on Thursday, where they both got emotional talking about the post's impact. Chappell received a certificate of appreciation during the unveiling of the \"Thunderbird\" and was told he is now forever part of the Spirals family. \"To know that it was a humble guy that just saw our need and did what he could. He doesn’t have a real following on social media, he hardly ever shares anything and to know that one post had so much power. It was super cool,\" Hosek added.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Arts, Culture and Entertainment",
      "Economy, Business and Finance"
    ],
    "external_links": [
      "https://www.usatoday.com/staff/7612431001/anthony-robledo/)",
      "https://spiralshotdogs.com/),",
      "https://www.spiralshotdogs.com/),",
      "https://usatoday.com/staff/7612431001/anthony-robledo/)"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "nick chappe",
          "sentiment": "negative"
        },
        {
          "name": "festler",
          "sentiment": "none"
        },
        {
          "name": "anthony robledo",
          "sentiment": "none"
        },
        {
          "name": "chappell",
          "sentiment": "none"
        },
        {
          "name": "chris",
          "sentiment": "none"
        },
        {
          "name": "scott festler",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "spiral hot dogs",
          "sentiment": "negative"
        },
        {
          "name": "customer",
          "sentiment": "negative"
        }
      ],
      "locations": [
        {
          "name": "norman",
          "sentiment": "none"
        },
        {
          "name": "usa",
          "sentiment": "none"
        },
        {
          "name": "oklahoma",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2023-12-29T02:25:18.910+02:00",
    "updated": "2023-12-29T06:27:26.644+02:00"
  },
  {
    "uuid": "8f13d9a12cb5ca7100643bff5e9ae2acd0f34593",
    "url": "https://www.finanzen.net/nachricht/aktien/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-2025-2034-as-breakthrough-therapies-gain-traction-delveinsight-14414886",
    "ord_in_thread": 0,
    "author": "Importer",
    "published": "2025-04-23T21:31:00Z",
    "title": "Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight | finanzen.net",
    "text": "Home Aktien Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight Die Top 10 Coins im Depot - mit dem finanzen.net Top 10 Crypto ETP. Jetzt informieren! Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight 23.04.25 23:31 Uhr Werbung The metastatic colorectal cancer (mCRC) market is experiencing significant growth, driven by advancements in targeted therapies, immunotherapies, and personalized medicine. The increasing prevalence of colorectal cancer, along with growing awareness of early diagnosis and treatment options, is fueling demand for innovative treatments.\nLAS VEGAS , April 23, 2025 /PRNewswire/ -- Colorectal cancer (CRC) ranks as the third most prevalent cancer, with metastasis being the leading cause of mortality among affected patients. The liver and peritoneum are the most frequent sites of distant spread. For most individuals, metastatic CRC (mCRC) remains largely incurable, with common metastatic locations including the liver, lungs, lymph nodes, and peritoneum.\nSeen in approximately 45% CRC patients, KRAS mutations significantly influence the prognosis and treatment outcomes. These mutations are associated with a more aggressive disease course, resistance to chemotherapy and targeted therapies, and overall poorer survival rates.\nIn 2024, the incidence of metastatic colorectal cancer was around 294K cases across the seven major markets, with the United States reporting the highest incidence. This number is expected to rise by 2034. Surgical intervention is the mainstay for resectable CRC, while unresectable cases are typically managed with chemotherapy, radiotherapy, and immunotherapy. These conventional therapies, however, often lack specificity and can harm healthy cells, leading to additional health complications.\nThe treatment paradigm for mCRC involves multiple lines of therapy. First-line (1L) metastatic colorectal cancer treatments include combination chemotherapy regimens such as FOLFOX, FOLFIRI, and CAPEOX , alongside anti-angiogenic agents and targeted therapies like VECTIBIX and ERBITUX , with or without chemotherapy. KEYTRUDA and BRAFTOVI (in combination with ERBITUX and mFOLFOX6) are also approved for use in the first line. In the second-line (2L) setting, treatment options expand to include OPDIVO (± YERVOY), JEMPERLI, TUKYSA (± Trastuzumab), LONSURF (± Bevacizumab), and KRAZATI plus ERBITUX . For third-line (3L) therapy, specific agents such as STIVARGA and FRUZAQLA are utilized.\nLearn more about the metastatic colorectal cancer treatment landscape @ Metastatic Colorectal Cancer Drugs Market\nFRUZAQLA (fruquintinib) is a once-daily oral capsule developed by Takeda Pharmaceuticals . It is a kinase inhibitor approved for adult patients with metastatic colorectal cancer who have previously been treated with chemotherapy regimens including fluoropyrimidine, oxaliplatin, and irinotecan, as well as anti-VEGF therapy and, for RAS wild-type patients, anti-EGFR therapy. FRUZAQLA works by selectively targeting and inhibiting VEGFR-1, -2, and -3, thereby disrupting VEGF-driven blood vessel formation and tumor growth.\nThe FDA approved FRUZAQLA for previously treated mCRC in November 2023 , followed by the European Commission in June 2024 , and Japan in September 2024—marking it as the first new targeted therapy for mCRC in more than ten years in the Japanese market.\nOPDIVO QVANTIG (nivolumab and hyaluronidase-nvhy) is indicated for adult patients with MSI-H or dMMR mCRC that has progressed after prior treatment with fluoropyrimidine, oxaliplatin, and irinotecan. It can be used as a standalone treatment or following prior combination therapy with intravenous nivolumab and ipilimumab. This drug works by blocking the PD-1 receptor, preventing its interaction with PD-L1 and PD-L2 to boost immune system activity against cancer cells.\nIn December 2024 , the FDA approved OPDIVO QVANTIG as a subcutaneous injection for mCRC, making it the first PD-1 inhibitor available in this form. This new route of administration offers quicker treatment delivery—just 3 to 5 minutes—compared to the traditional 30-minute intravenous infusion of OPDIVO.\nTo know more about metastatic colorectal cancer treatments, visit @ Metastatic Colorectal Cancer Aggressive Treatment\nDespite several advancements, the metastatic colorectal cancer drug market remains highly competitive, with significant unmet needs for durable and long-term treatment responses. Ongoing research into investigational agents like amivantamab, zanzalintinib, and vactosertib highlights the push for more effective, resistance-targeting, and tumor microenvironment-modifying therapies, signaling a dynamic and evolving future for mCRC treatment.\nKey companies such as Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Inspirna, Treos Bio, Cardiff Oncology, Agenus, Leap Therapeutics, Arcus Biosciences, Enterome, Tizona Therapeutics, Innovative Cellular Therapeutics , and others are currently active in the metastatic colorectal cancer drug market.\nDiscover which therapies are expected to grab major metastatic colorectal cancer drug market share @ Metastatic Colorectal Cancer Market Report\nAmivantamab is a bispecific antibody designed to target specific genetic alterations, especially EGFR exon 20 insertion mutations. Its dual mechanism focuses on inhibiting both the Epidermal Growth Factor Receptor (EGFR) and the MET receptor—two key players in cancer cell growth and survival. By binding to these receptors, amivantamab interferes with their signaling pathways, helping to overcome resistance that tumors often develop to other treatments.\nThis dual targeting not only suppresses tumor cell growth but also enhances the body's immune response, leading to greater cancer cell destruction. The drug is currently in Phase III clinical trials for treating metastatic colorectal cancer (mCRC).\nZanzalintinib (XL-092) is a third-generation oral tyrosine kinase inhibitor that blocks several cancer-related receptor tyrosine kinases, including VEGF receptors, MET, AXL, and MER. These kinases play a role in normal cell function as well as pathological processes like cancer development, metastasis, angiogenesis, and resistance to therapies such as immune checkpoint inhibitors. Developed by Exelixis , Zanzalintinib builds on the company's experience with cabozantinib, aiming to improve attributes like pharmacokinetic half-life. It is also in Phase III clinical trials for mCRC.\nDKN-01 is a humanized monoclonal antibody that targets the DKK1 protein and is being developed for treating esophagogastric, gynecologic, and colorectal cancers. Initial findings from Part A of the DeFianCe trial were shared at the 2024 ASCO Gastrointestinal Cancers Symposium. Enrollment for Part B of the DeFianCe trial (NCT05480306) concluded in September 2024 . This Phase II, randomized, open-label, controlled study is assessing DKN-01 in combination with bevacizumab and chemotherapy as a second-line treatment for advanced colorectal cancer in patients previously treated with one systemic therapy. The study enrolled 188 patients, with early results anticipated by mid-2025.\nDiscover more about drugs for metastatic colorectal cancer in development @ Metastatic Colorectal Cancer Clinical Trials\nThe anticipated launch of these emerging metastatic colorectal cancer treatments are poised to transform the market landscape in the coming years. As these cutting-edge therapies continue to mature and gain regulatory approval, they are expected to reshape the metastatic colorectal cancer market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth.\nDelveInsight estimates that the market size for metastatic colorectal cancer in the 7MM is expected to grow from USD 13 billion in 2024 with a significant CAGR by 2034. This growth is fueled by advancements in precision medicine, including targeted therapies and immunotherapies, which have shown promise in improving patient outcomes.\nDelveInsight's latest published market report titled as Metastatic Colorectal Cancer Market Insight, Epidemiology, and Market Forecast – 2034 will help you to discover which market leader is going to capture the largest market share. The report provides comprehensive insights into the metastatic colorectal cancer country-specific treatment guidelines, patient pool analysis, and epidemiology forecast to help understand the key opportunities and assess the market's underlying potential. The metastatic colorectal cancer market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM, segmented into:\nTotal Incident Cases of CRC Gender-specific Cases of CRC Age-specific Cases of CRC Tumor Location-specific Cases of CRC Stage-specific Cases of CRC Total Incident Cases of mCRC Mutation Type-specific Cases of mCRC Total Treated Cases of mCRC by Line of Therapy The report provides an edge while developing business strategies by understanding trends shaping and driving the 7MM metastatic colorectal cancer market. Highlights include:\n10-year Forecast 7MM Analysis Epidemiology-based Market Forecasting Historical and Forecasted Market Analysis upto 2034 Emerging Drug Market Uptake Peak Sales Analysis Key Cross Competition Analysis Industry Expert's Opinion Access and Reimbursement Download this metastatic colorectal cancer market report to assess the epidemiology forecasts, understand the patient journeys, know KOLs' opinions about the upcoming treatment paradigms, and determine the factors contributing to the shift in the metastatic colorectal cancer market. Also, stay abreast of the mitigating factors to improve your market position in the metastatic colorectal cancer therapeutic space.\nRelated Reports\nMetastatic Colorectal Cancer Pipeline\nMetastatic Colorectal Cancer Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key metastatic colorectal cancer companies, including Shanghai Henlius Biotech, Eisai Inc., Treos Bio, AUM Biosciences, Leap Therapeutics, Inc., Hoffmann-La Roche, Replimune, Qilu Pharmaceutical, Lutris Pharma, Ipsen, Bold Therapeutics, Pacylex Pharmaceuticals, FivepHusion, SystImmune, Inspirna, Inc., Sapience Therapeutics, Exelixis, Daiichi Sankyo, Hutchmed, Merus N.V., REVOLUTION Medicines, Pure Tech Health, Medicenna Therapeutics, Inc., Verastem Inc., Next Cure Inc., Isofol Medical, Zentalis Pharmaceuticals, Oncoinvent, KaryoPharm Therapeutics, Aadi Biosciences, among others.\nMetastatic Colorectal Cancer Market\nMetastatic Colorectal Cancer Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key metastatic colorectal cancer companies, including Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Inspirna, Treos Bio, Cardiff Oncology, Agenus, Leap Therapeutics, Arcus Biosciences, Enterome, Tizona Therapeutics, Innovative Cellular Therapeutics, among others.\nColorectal Cancer Market\nColorectal Cancer Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key colorectal cancer companies, including Mirati Therapeutics, Exelixis, Enterome, Arcus Biosciences, Lyell Immunopharma, AstraZeneca, Novartis Pharmaceuticals, Surgimab, Numab Therapeutics, SOTIO Biotech, Amgen, Sichuan Baili Pharmaceutical, Qilu Pharmaceutical, Bristol-Myers Squibb, NGM Biopharmaceuticals, Takeda, PureTech, Pfizer, Kezar Life Sciences, Salubris Biotherapeutics, among others.\nColorectal Cancer Pipeline\nColorectal Cancer Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key colorectal cancer companies, including Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences, Inc, Neogap Therapeutics AB, Criterium, Inc, Daiichi Sankyo, Inc, Bristol-Myers Squibb, Celyad Oncology SA, Pfizer, Akeso, Menarini Group, Elpiscience (Suzhou) Biopharma, Ltd., BeyondBio Inc., Shanghai Henlius Biotech, Rottapharm Biotech, Innovative Cellular Therapeutics Inc., BioNTech SE, among others.\nAbout DelveInsight\nDelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve .\nContact Us\nShruti Thakur\ninfo@delveinsight.com\n+14699457679\nLogo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg\nView original content: https://www.prnewswire.com/news-releases/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-20252034-as-breakthrough-therapies-gain-traction--delveinsight-302435372.html\nSOURCE DelveInsight Business Research, LLP",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "topics": [
      "Health->cancer",
      "Health->medical specialisation",
      "Health->health treatment and procedure",
      "Science and Technology->scientific research",
      "Science and Technology->medical research",
      "Science and Technology->biomedical science"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://www.delveinsight.com/report-store/colorectal-cancer-crc-pipeline-insight?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://www.prnewswire.com/news-releases/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-20252034-as-breakthrough-therapies-gain-traction--delveinsight-302435372.html",
      "https://www.delveinsight.com/report-store/colorectal-cancer-crc-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://delveinsight.com/report-store/colorectal-cancer-crc-pipeline-insight?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://delveinsight.com/report-store/colorectal-cancer-crc-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://delveinsight.com/report-store/metastatic-colorectal-cancer-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://delveinsight.com/sample-request/metastatic-colorectal-cancer-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr",
      "https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-market",
      "https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-market",
      "https://prnewswire.com/news-releases/metastatic-colorectal-cancer-market-poised-for-expansion-across-the-7mm-during-the-forecast-period-20252034-as-breakthrough-therapies-gain-traction--delveinsight-302435372.html",
      "https://www.delveinsight.com/report-store/colorectal-cancer-crc-market",
      "https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight",
      "https://www.delveinsight.com/report-store/colorectal-cancer-crc-pipeline-insight"
    ],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": [
        {
          "name": "Crypto ETP",
          "sentiment": "none",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T01:06:00.519+03:00",
    "updated": "2025-04-24T01:06:00.519+03:00"
  },
  {
    "uuid": "8a1fd35e2030b4c30d6ee8c530dcc94a00d654d4",
    "url": "https://www.sopitas.com/noticias/salvar-vidas-pandemia-covid-mexico-comision-independiente",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Sopibecario",
    "published": "2024-04-04T22:12:00Z",
    "title": "Se pudieron salvar 224 mil vidas durante la pandemia de COVID en México: Comisión Independiente",
    "text": "Lo que necesitas saber:\nLa Comisión Independiente para investigación de la pandemia de COVID publica sus primeros resultados.\nRecientemente la Comisión Independiente de Investigación sobre la pandemia de COVID-19 en México publicó sus resultados preliminares: se pudieron haber salvado más de 224 mil vidas.\nFue el 6 de febrero pasado cuando la Comisión independiente\nanunció su integración para analizar las decisiones y los resultados del manejo de la pandemia en nuestro país.\nLos primeros resultados de la Comisión Independiente sobre COVID en México\nDesde hace varios meses la Comisión Independiente está llevando a cabo una investigación sobre la pandemia de\nCOVID-19 en México. Recientemente anuncian sus resultados preliminares enfocados en 5 principales puntos:\n- Que hubo fallas graves en la toma de decisiones incluyendo la personalización excesiva, la persistencia en el error, así como el rechazo a la deliberación y evidencia científica\n- Que se minimizó la gravedad de la situación, hubo uso engañoso de datos, justificaron decisiones políticas de manera pseudo-científica y además decidieron gestionar la percepción de la sociedad en vez de gestionar la crisis sanitaria.\n- Que antes de la pandemia el sistema de salud ya estaba segmentado y en un estado financiero precario, cosas que empeoraron la capacidad de responder a la crisis.\n- Que los sectores populares y grupos vulnerables quedaron desprotegidos por falta de estímulos económicos, aumento del gasto familiar en salud, así como el impacto en mortalidad, orfandad y esperanza de vida.\n- Que se pudieron haber salvado 224 mil 244 vidas si la pandemia se hubiera manejado de manera distinta.\nPero ¿cómo calcularon que se pudieron haber salvado más de 200 mil vidas durante la pandemia de COVID en México?\nEl doctor Jaime Sepúlveda, integrante de la Comisión independiente, explica que este número salió de una metodología en la que compararon todos los países del mundo con población mayor a 3 millones de habitantes con una serie de características estructurales como demografía, economía, enfermedades per-existentes, etc.\nAsí fue como obtuvieron el aproximado de fallecimientos por fallas estructurales que todos los países tuvieron en mayor o menor grado y cuales ocurrieron por una mala gestión.\nEl director de la Comisión explica que este informe no solo es para entender qué pasó con la pandemia, sino también para que el país tome las medidas necesarias para enfrentar nuevas emergencias sanitarias en el futuro.\n“Nuestro propósito es aprender para no repetir, es decir, sacar todas las lecciones posibles de lo que sucedió con el fin de que, cuando se presente otra emergencia sanitaria, nuestro país no vuelva a pagar un costo tan elevado en vidas, salud y bienestar“, se lee en el comunicado.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Social Issue",
      "Health"
    ],
    "external_links": [
      "https://comisioncovid.mx/comunicados/boletin-de-prensa.html",
      "https://www.comisioncovid.mx/comunicados/boletin-de-prensa.html"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-04-05T02:24:22.881+03:00",
    "updated": "2024-04-05T02:24:22.881+03:00"
  },
  {
    "uuid": "530c81b3550e7e740d879984529b5a67901f56ff",
    "url": "https://www.indiaherald.com/Breaking/Read/994831328/Struggling-With-Excessive-Blood-Strain-",
    "ord_in_thread": 0,
    "author": "G GOWTHAM",
    "published": "2025-07-03T05:37:47Z",
    "title": "Struggling With Excessive Blood Strain?",
    "text": "Excessive blood strain, or hypertension, is a silent health condition that could lead to extreme headaches like coronary heart sickness, stroke, and kidney issues if left unmanaged. The best information is that with the proper life-style changes, you could correctly decrease your blood strain and guard your heart — regularly with out heavy reliance on medicinal drug.\n1. Undertake a heart-healthy diet (sprint weight loss plan)\nFocus on fruits, vegetables, complete grains, and coffee-fats dairy\nLessen intake of salt, saturated fat, and beef\nEncompass potassium-rich foods like bananas, spinach, and sweet potatoes to stability sodium ranges\n2. Get normal physical activity\nAim for half-hour of mild exercising (like walking, biking, or swimming) most days of the week. Bodily pastime strengthens your coronary heart and enables hold a wholesome weight.\n3. Cut lower back on Sodium\nToo much salt retains water and increases strain for your arteries. Maintain your sodium consumption under 2,three hundred mg/day, or maybe lower if advised by using your health practitioner.\n4. Manage strain\nPersistent strain can enhance blood pressure. Strive deep respiration, meditation, yoga, journaling, or spending time in nature to relax your thoughts and frame.\n5.keep away from Smoking and restriction Alcohol\nNicotine tightens blood vessels and increases strain\nExtra alcohol (more than 1–2 liquids/day) can damage your heart\n6. Hold a healthy Weight\nEven a small discount in weight can notably decrease your blood stress if you're overweight.\n7. Display Your bp at home\nHold a log of your readings to tune progress and proportion with your healthcare company. Early detection can assist save you complications.\nConclusion:\nExcessive blood strain may be controlled effectively with constant life-style adjustments, focus, and clinical guide if wished. Take manage nowadays — your coronary heart and future self will thanks.\nDisclaimer: This content has been sourced and edited from Indiaherald. While we have made adjustments for clarity and presentation, the unique content material belongs to its respective authors and internet site. We do not claim possession of the content material.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Human Interest",
      "Lifestyle and Leisure"
    ],
    "topics": [
      "Health->medical condition",
      "Health->health treatment and procedure",
      "Health->heart disease",
      "Lifestyle and Leisure->lifestyle",
      "Lifestyle and Leisure->wellness"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "top_news": [],
      "bias": null
    },
    "rating": null,
    "crawled": "2025-07-03T08:37:47.498+03:00",
    "updated": "2025-07-03T05:43:56.000+00:00"
  }
]